Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
Ahmed Bennis, Professor of Cardiology at Ibn Rochd University Hospital, shared on X։
”The Role of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction․
CMD is an independent predictor for future adverse outcomes in the HFpEF population.
CMD and HFpEF share pathophysiological links, although a direct causal relationship remains unproven.
Comprehensive CMD assessment in HFpEF can improve risk stratification and guide targeted therapeutic strategies.”
Read the full article here.
Article: The Role of Coronary Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
Authors: Andreas Tzoumas, Danielle Tapp, Daniela Crousillat, Michael C. Honigberg, Patricia F. Rodriguez-Lozano, Niti R. Aggarwal, Imo A. Ebong, Joan Briller, Glaucia Moraes De Oliveira, Colleen M. Harrington, Selma F. Mohammed, Noel Bairey Merz, Timothy D. Henry, and Odayme Quesada
Stay updated with Hemostasis Today.
-
Feb 23, 2026, 18:13Fight4Hematology Supports Research and Empowers the Next Generation – ASH
-
Feb 23, 2026, 17:59Wolfgang Miesbach: Real-World Evidence of Emicizumab on Joint Outcomes in Hemophilia A
-
Feb 23, 2026, 17:56Shiny K Kajal: The Transfusion Reaction We Often Miss
-
Feb 23, 2026, 17:53Radheshyam Meher: Contributing to the Transfusion Evidence Round-Up for International Childhood Cancer Day 2026
-
Feb 23, 2026, 17:46Mahesan Subramaniam: The Physiological Impact of Anger on Immunity
-
Feb 23, 2026, 17:42Bryan Fry: First Evidence That Bothrops atrox Venom Directly Activates Human Factor VII
-
Feb 23, 2026, 17:34Bastu Odoka: Why Blood Should NOT be Left at the Bedside to ‘Warm’
-
Feb 23, 2026, 17:28Henry Burkitt: Patients Are Challenging How the Medicines Policy System Works in England
-
Feb 23, 2026, 16:50Mutaz Al‑Sabah: Interesting Webinar on FH in Women is Now Available to Watch